153 related articles for article (PubMed ID: 27779171)
1. Knockdown of Decoy Receptor 3 Impairs Growth and Invasiveness of Hepatocellular Carcinoma Cell Line of HepG2.
Zhou XN; Li GM; Xu YC; Zhao TJ; Wu JX
Chin Med J (Engl); 2016 Nov; 129(21):2623-2629. PubMed ID: 27779171
[TBL] [Abstract][Full Text] [Related]
2. Silencing of decoy receptor 3 (DcR3) expression by siRNA in pancreatic carcinoma cells induces Fas ligand-mediated apoptosis in vitro and in vivo.
Zhou J; Song S; He S; Wang Z; Zhang B; Li D; Zhu D
Int J Mol Med; 2013 Sep; 32(3):653-60. PubMed ID: 23846297
[TBL] [Abstract][Full Text] [Related]
3. The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells.
Zhao T; Xu Y; Ren S; Liang C; Zhou X; Wu J
Exp Ther Med; 2018 May; 15(5):4370-4378. PubMed ID: 29725377
[TBL] [Abstract][Full Text] [Related]
4. Decoy receptor 3 suppresses FasL-induced apoptosis via ERK1/2 activation in pancreatic cancer cells.
Zhang Y; Li D; Zhao X; Song S; Zhang L; Zhu D; Wang Z; Chen X; Zhou J
Biochem Biophys Res Commun; 2015 Aug; 463(4):1144-51. PubMed ID: 26102031
[TBL] [Abstract][Full Text] [Related]
5. Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.
Hayashi S; Miura Y; Nishiyama T; Mitani M; Tateishi K; Sakai Y; Hashiramoto A; Kurosaka M; Shiozawa S; Doita M
Arthritis Rheum; 2007 Apr; 56(4):1067-75. PubMed ID: 17393415
[TBL] [Abstract][Full Text] [Related]
6. 'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.
Toda M; Kawamoto T; Ueha T; Kishimoto K; Hara H; Fukase N; Onishi Y; Harada R; Minoda M; Kurosaka M; Akisue T
Int J Oncol; 2013 Sep; 43(3):703-12. PubMed ID: 23817777
[TBL] [Abstract][Full Text] [Related]
7. Effects of miR-340 on hepatocellular carcinoma by targeting the DcR3 gene.
Xie L; Chen Z; Liu H; Guan L; Wang Z; Li W
Dig Liver Dis; 2018 Mar; 50(3):291-296. PubMed ID: 29311025
[TBL] [Abstract][Full Text] [Related]
8. Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1.
Xu YC; Cui J; Zhang LJ; Zhang DX; Xing BC; Huang XW; Wu JX; Liang CJ; Li GM
Chin Med J (Engl); 2018 Jan; 131(1):82-87. PubMed ID: 29271385
[TBL] [Abstract][Full Text] [Related]
9. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
Zhang J; Zhang DL; Jiao XL; Dong Q
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
[TBL] [Abstract][Full Text] [Related]
10. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
Chen C; Zhang C; Zhuang G; Luo H; Su J; Yin P; Wang J
Cancer Invest; 2008 Dec; 26(10):965-74. PubMed ID: 19093253
[TBL] [Abstract][Full Text] [Related]
11. DcR3 promotes hepatoma cell migration by downregulating E-cadherin expression.
Zhang H; Chen X; Li D; Cui L; Li X; Ye X; Wan X
Oncol Rep; 2017 Jul; 38(1):377-383. PubMed ID: 28560426
[TBL] [Abstract][Full Text] [Related]
12. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.
Chen PH; Yang CR
J Immunol; 2008 Dec; 181(12):8441-9. PubMed ID: 19050262
[TBL] [Abstract][Full Text] [Related]
13. The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma.
Weissinger D; Tagscherer KE; Macher-Göppinger S; Haferkamp A; Wagener N; Roth W
Mol Cancer; 2013 Oct; 12(1):120. PubMed ID: 24107265
[TBL] [Abstract][Full Text] [Related]
14. [Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis].
Yu DD; Yao M; Chen J; Wang L; Yan MJ; Gu X; Qiu LW; Dong ZZ; Yao DF; Lu SL
Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):452-8. PubMed ID: 24034848
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3.
Im J; Kim K; Hergert P; Nho RS
J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
Shen HW; Gao SL; Wu YL; Peng SY
World J Gastroenterol; 2005 Oct; 11(38):5926-30. PubMed ID: 16273601
[TBL] [Abstract][Full Text] [Related]
18. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
Hsieh SL; Lin WW
J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
[TBL] [Abstract][Full Text] [Related]
19. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts.
Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M
Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906
[TBL] [Abstract][Full Text] [Related]
20. DcR3-TL1A signalling inhibits cytokine-induced proliferation of rheumatoid synovial fibroblasts.
Takahashi M; Miura Y; Hayashi S; Tateishi K; Fukuda K; Kurosaka M
Int J Mol Med; 2011 Sep; 28(3):423-7. PubMed ID: 21537832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]